PORTFOLIO MANAGEMENT
Fund Screener
Pipeline management and fast GP track record screening.
Quicker, easier pipeline management to streamline the underwriting process.
CEPRES Fund Screener is an easy-to-use pipeline and track record screening solution that lets investors manage their forward calendar and quickly screen GP track records for shortlisting in less time.
CEPRES enables fast and accurate analysis on real track records permissioned by GPs so investors can quickly know how they align with your portfolio goals. Combined with fund level benchmarking against 13,000 funds, this empowers investors with faster decisions of which GPs to take through full due diligence.
Automated analysis includes standard fund, deal and portfolio company KPIs like cash pacing, leverage, deal pricing, value creation, EBITDA growth and much more.
Because if you don’t have CEPRES, you don’t know.
Features
Portfolio Management Solutions
Analysis Builder
Unlimited data and analysis customization of CEPRES’ look-through data across all portfolio levels.
Due Diligence
Fast and customizable GP track record analysis with fund, deal, and operating-level benchmarking to enhance underwriting decisions.
Portfolio Monitoring
Fund, deal, co-investment and portfolio company look through for all private markets asset classes; benefit from the industry’s highest quality private markets data.
Predictive Intelligence
AI-based portfolio simulation and tracking software utilizing multi-factor and Monte Carlo simulations to forecast portfolio outcomes and improve ALM and asset allocation planning.
Analysis Builder
Unlimited data and analysis customization of CEPRES’ look-through data across all portfolio levels.
Due Diligence
Fast and customizable GP track record analysis with fund, deal, and operating-level benchmarking to enhance underwriting decisions.
Portfolio Monitoring
Fund, deal, co-investment and portfolio company look through for all private markets asset classes; benefit from the industry’s highest quality private markets data.
Predictive Intelligence
AI-based portfolio simulation and tracking software utilizing multi-factor and Monte Carlo simulations to forecast portfolio outcomes and improve ALM and asset allocation planning.
Featured Content
The PE industry has grown rapidly over the last two decades, recording an extraordinary increase in funds raised, fund size, deal volume, and overall deal size. But a perennial challenge – illiquidity – has remained largely unresolved, until now.
The Solactive CEPRES US Private Equity Industry Replicator Index is a new approach that provides return exposure to the return profile of buyout funds focused on North America.
This new replication approach, based on reweighting publicly listed equities, can deliver a similar performance to the North American private equity sector.
Insights
Introducing the DealEdge Free Trial: Unlock Market Insights with CEPRES Data
We’re excited to introduce the DealEdge Free Trial, powered by CEPRES' exclusive data. With the launch of this free trial, we’re also proud to announce that DealEdge has crossed the threshold to over 50,000 deals, covering 570+ subsectors and 200+ countries from 1970 to 2024.
How will the decline in interest rates affect the private capital markets?
The twenty-first century has experienced a range of different interest rate regimes - from the aperiodic near-zero interest rate environment of most of the 2010s to the fluctuations seen in the early 2000s, and now again (more sharply) in the 2020s.
Introducing the DealEdge Free Trial: Unlock Market Insights with CEPRES Data
We’re excited to introduce the DealEdge Free Trial, powered by CEPRES' exclusive data. With the launch of this free trial, we’re also proud to announce that DealEdge has crossed the threshold to over 50,000 deals, covering 570+ subsectors and 200+ countries from 1970 to 2024.
How will the decline in interest rates affect the private capital markets?
The twenty-first century has experienced a range of different interest rate regimes - from the aperiodic near-zero interest rate environment of most of the 2010s to the fluctuations seen in the early 2000s, and now again (more sharply) in the 2020s.